News and Events

What's new and upcoming with EarlySign

News

Forbes: Israel Applies AI To Healthcare, Building On Leadership In Cybersecurity, Digital Medical Records

Israeli AI System Helps Save Lives by Flagging Patients at High Risk of Flu Complications

Israel launches its first AI-powered flu vaccination campaign

EarlySign, Maccabi Healthcare Launches AI-Powered Flu Vaccination Campaign

– Medial EarlySign unveils the first clinical implementation of its AI-based solution to identify unvaccinated individuals at high-risk of developing serious flu-related complications.

Predictive Patient Care Startup Medial EarlySign Partners With Israeli HMO on Flu Vaccine Campaign

EarlySign combines machine-learning technology and decades-worth of electronic health records (EHR) to create an artificial intelligence-based disease risk predictor

Maccabi Healthcare Services Teams Up with EarlySign on Israel’s First AI-Powered Flu Vaccination Campaign

Leading Israeli HMO Evaluates the Clinical Use of EarlySign’s Algorithm to Identify Patients at High Risk of Flu Complications

Press Releases

Medial EarlySign Expands Executive Team Amid U.S. Growth

January 14, 2020

AI Health Leader Appoints Three New Senior Executives to Support Growing Customer Base

Learn More

Maccabi Healthcare Services Teams Up with EarlySign on Israel’s First AI-Powered Flu Vaccination Campaign

January 13, 2020

Leading Israeli HMO Evaluates the Clinical Use of EarlySign’s Algorithm to Identify Patients at High Risk of Flu Complications

Learn More

Geisinger and Medial EarlySign Advance to First Stage of CMS AI Health Outcomes Challenge

November 19, 2019

Joint Proposal to Reduce Adverse Events and Avoidable Hospital Readmissions Selected Among Top 25 Submissions

Learn More

EarlySign Selects Chief Medical Officer Dr. Jeremy Orr as New CEO

October 29, 2019

TEL AVIV, Israel – October 29, 2019 – EarlySign (earlysign.com), a leader in machine learning-based solutions to aid in the early detection and prevention of high-burden diseases, today announced the appointment of Jeremy Orr, MD, MPH, as its new Chief Executive Officer.

Learn More

New Study Shows EarlySign’s Machine Learning Algorithm Can Predict Which Cardiac Patients are at High-Risk Following Discharge

September 4, 2019

TEL AVIV, Israel and ROCHESTER, MN – September 4, 2019 – Medial EarlySign (earlysign.com), a leader in machine-learning based solutions to aid in early detection and prevention of high-burden diseases, today announced the results of new research with Mayo Clinic assessing the effectiveness of machine learning for predicting cardiac patients’ future risk trajectories following hospital discharge.

Learn More

Geisinger Taps EarlySign™ for New Range of AI Solutions to Identify Patients at Risk of High-Burden Diseases

July 10, 2019

Multi-Year Partnership to Apply Lower GI Algorithms as First Step in Improving Patient Outcomes Through Personalized and Population Health Strategies

Learn More

Events

Medial EarlySign Sponsors HIMSS Machine Learning & AI for Healthcare Forum

Medial EarlySign is proud to co-sponsor the Machine Learning & AI for Healthcare Forum at HIMSS2O. Beginning with the essential foundation of data and analytics competency, the discussion will move on to real-world applications of machine learning and artificial intelligence, focusing on best practices for implementation and integration.

Medial EarlySign Sponsors NCCRT Annual Meeting

Medial EarlySign is proud to attend and co-sponsor the 2019 Annual Meeting of the National Colorectal Cancer Roundtable (NCCRT).

Medial EarlySign Presenting at Lab Institute 2019

Medial EarlySign’s CMO, Dr. Jeremy Orr, will be speaking at a session entitled “Analyte to Algorithm to Action to Impact” at G2 Intelligence’s 37th Annual Lab Institute.

Medial EarlySign at the HLTH Conference

Medial EarlySign is looking forward to attending the HTLH conference next month in Las Vegas.

Medial EarlySign Presenting at MedCity CONVERGE

MedCity CONVERGE brings together all sectors of the oncology ecosystem — health systems, insurers, digital health, investors, hospitals, pharma, entrepreneurs and other key stakeholders — to discover the latest innovations and the future of cancer care.

Medial EarlySign Exhibiting at American Diabetes Association’s 79th Scientific Sessions

The American Diabetes Association’s 79th Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care.

News and Events

What's new and upcoming with EarlySign

News

Forbes: Israel Applies AI To Healthcare, Building On Leadership In Cybersecurity, Digital Medical Records

Israeli AI System Helps Save Lives by Flagging Patients at High Risk of Flu Complications

Israel launches its first AI-powered flu vaccination campaign

EarlySign, Maccabi Healthcare Launches AI-Powered Flu Vaccination Campaign

Predictive Patient Care Startup Medial EarlySign Partners With Israeli HMO on Flu Vaccine Campaign

Maccabi Healthcare Services Teams Up with EarlySign on Israel’s First AI-Powered Flu Vaccination Campaign

Press Releases

Medial EarlySign Expands Executive Team Amid U.S. Growth

Maccabi Healthcare Services Teams Up with EarlySign on Israel’s First AI-Powered Flu Vaccination Campaign

Geisinger and Medial EarlySign Advance to First Stage of CMS AI Health Outcomes Challenge

EarlySign Selects Chief Medical Officer Dr. Jeremy Orr as New CEO

New Study Shows EarlySign’s Machine Learning Algorithm Can Predict Which Cardiac Patients are at High-Risk Following Discharge

Geisinger Taps EarlySign™ for New Range of AI Solutions to Identify Patients at Risk of High-Burden Diseases

Events

Medial EarlySign Sponsors HIMSS Machine Learning & AI for Healthcare Forum

Medial EarlySign Sponsors NCCRT Annual Meeting

Medial EarlySign Presenting at Lab Institute 2019

Medial EarlySign at the HLTH Conference

Medial EarlySign Presenting at MedCity CONVERGE

Medial EarlySign Exhibiting at American Diabetes Association’s 79th Scientific Sessions

Are you looking to solve high-burden disease challenges?

Solutions

Technology

Knowledge Center

Who We Serve

About Us

Knowledge Center

About Us